Articles
-
Efforts to Save Money on Prescription Drugs Associated with Increased Stroke Risk for Seniors
Tools used by insurers and PBMs to contain costs result in fewer patients using NOACs or warfarin
Categorized in -
Drugmakers Aren’t Driving Inflation. Price Controls Would Hinder Medical Progress
Drug prices have not experienced the major rise in cost like eggs or gasoline, and instituting price controls on drugs would only stifle medical innovation.
Categorized in -
Lack of Diversity in Clinical Trials Costs Billions of Dollars. Incentives Can Spur Innovation
Economic incentives to recruit more diverse participants for clinical trials are available and could save the U.S. billions of dollars.
Categorized in -
Largest Medicare Advantage Plans Pay Big Markups for Dialysis
Large dialysis chains charge Medicare Advantage plans 27% more than the traditional, fee-for-service Medicare program.
Categorized in -
Risk for Heart Attack, Stroke or Death Can Double or Triple in Older Adults Concurrently Taking Multiple Medications with Cardiovascular Side Effects
Using multiple medications with known cardiovascular adverse effects at the same time substantially increases cardiovascular risk.
Categorized in -
Bringing Back a Mask Mandate in Los Angeles County is Unjustified
Schaeffer Center experts argue in a recent op-ed that Los Angeles County hasn’t met the threshold for a mask mandate.
Categorized in -
Benzodiazepines Don’t Increase Dementia Risks in Older Adults, USC Study Finds
There is little evidence that older adults prescribed benzodiazepines are at increased risk of developing dementia.
-
Cannabis Regulations Inadequate Given Rising Health Risks of High-Potency Products
A new USC Schaeffer Center white paper shows how state-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.
Categorized in -
The Supreme Court Left Millions of Americans Uninsured: Here’s What Congress Can Do to Cover Them
Congress can expand healthcare to millions of Americans by enrolling individuals in the 12 states that did not expand Medicaid.
Categorized in -
The Cantwell-Grassley PBM Bill Is Much Needed But More Can Be Done
The proposed reforms are a helpful start, but could go further in addressing the lack of competition in the U.S. PBM market.
Categorized in